A biotech startup is hoping to bring a pill to market as soon as 2025 that could give dogs at least an extra year of healthy life. San Francisco-based Loyal has raised 125-million-dollars to develop the drug with the hopes that the work can also eventually benefit humans. The daily pill looks to lessen or reverse a dog's metabolic changes as it gets older.